Characteristics of subjects according to persistence with antiplatelets at 6 months.

Figshare2021-02-09 更新2026-04-28 收录

数据链接：

https://figshare.com/articles/dataset/Characteristics_of_subjects_according_to_persistence_with_antiplatelets_at_6_months_/13814811 数据链接链接失效反馈

官方服务：

资源简介：

Characteristics of subjects according to persistence with antiplatelets at 6 months.

创建时间：

2021-02-09

Supplementary Material for: Rationale, Design and Baseline Data of a Randomized, Double-Blind, Controlled Trial Comparing Two Antithrombotic Regimens (a Fixed-Dose Combination of Extended-Release Dipyridamole plus ASA with Clopidogrel) and Telmisartan versus Placebo in Patients with Strokes: The Prevention Regimen for Effectively Avoiding Second Strokes Trial (PRoFESS)

中风预防

抗血小板治疗

Background: Individuals with transient ischemic attack and ischemic stroke have a high risk of recurrent stroke and death. While acetylsalicylic acid (ASA, aspirin) is proven and accepted as st

DataCite Commons2020-09-02 更新130

Predicting short-term interruptions of antiretroviral therapy from summary adherence data: Development and test of a probability model

治疗中断预测

用药依从性

Antiretroviral therapy (ART) for HIV is vulnerable to unplanned treatment interruptions–consecutively missed doses over a series of days–which can result in virologic rebound. Yet clinicians lack a si

NIAID Data Ecosystem60

Additional file 9 of Accuracy and concordance of measurement methods to assess non-adherence after renal transplantation - a prospective study

移植术后管理

用药依从性

Additional file 9. a: Course of unadjusted means of the self-assessed intervention effect. 9 b: Boxplots for the self-assessed intervention effect.

Figshare2020-03-31 更新50

Baseline characteristics.

抗血小板治疗

围手术期风险评估

Background Despite Antiplatelet therapy (APT), cardiovascular patients undergoing revascularisation remain at high risk for thrombotic events. Individual response to APT varies substantially, resultin

NIAID Data Ecosystem60

Association between experiencing side effects of artesunate/amodiaquine malaria chemoprevention (ASAQ-CP) in the first round of mass drug administration (MDA) with initiation of ASAQ-CP in the second round of the MDA, during the Ebola outbreak, Monrovia, Liberia, 2014 (Poisson regression).

疟疾化学预防效果评估

用药依从性

Association between experiencing side effects of artesunate/amodiaquine malaria chemoprevention (ASAQ-CP) in the first round of mass drug administration (MDA) with initiation of ASAQ-CP in the second

NIAID Data Ecosystem50

Characteristics of subjects according to persistence with antiplatelets at 6 months.

资源简介：

相关数据集